The US Food and Drug Administration has issued draft guidance intended to promote consistency in reviewing medical device submissions to the agency that incorporate physiologic closed-loop control (PCLC) technology.
The FDA in drafting its 23 December guidance incorporated feedback from a 2015 workshop held by the agency’s device center, during which manufacturers, clinical